Gentry Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$975K Buy
813
+102
+14% +$104K 0.5% 29
2026
Q1
$654K Buy
711
+221
+45% +$224K 0.39% 39
2025
Q4
$527K Buy
+490
New +$469K 0.33% 42

Other funds holding LLY

Gentry Private Wealth's LLY Position: Q2 2026 in Review

Gentry Private Wealth increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $104K and bringing the position to 813 shares worth $975K. The position accounts for 0.5% of the portfolio, ranked #29.

Gentry Private Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gentry Private Wealth held 813 shares of Eli Lilly worth $975K as of Q2 2026.
  • Gentry Private Wealth bought 102 Eli Lilly shares in Q2 2026, an estimated $104K.
  • Eli Lilly made up 0.5% of Gentry Private Wealth's portfolio in Q2 2026, its #29 holding.
  • Gentry Private Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gentry Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.